BIO-Europe® 2015: Interview with Anthony Walker, Alacrita

November 19, 2015
Mike Ward, global director of content for Informa Pharma Insights, chats with Anthony Walker, managing partner of life sciences consulting firm Alacrita, at BIO-Europe in Munich Germany, about what's wrong with risk adjusted net present values. They cover the problem with this tool, other methods of probability assessment, and how companies should be negotiating prices. Find more videos and articles at http://www.partnering360.com/insight For more information on BIO-Europe, visit our webpage: http://www.ebdgroup.com/beu/index.php
Previous Video
BIO-Europe® 2015: Interview with Richard Onyett, ADC Therapeutics
BIO-Europe® 2015: Interview with Richard Onyett, ADC Therapeutics

Richard Onyett, business development director of ADC Therapeutics, chats with Mike Ward, global director of...

Next Video
BIO-Europe® 2015: Interview with Alec McLean, Lamellar Biomedical Ltd
BIO-Europe® 2015: Interview with Alec McLean, Lamellar Biomedical Ltd

Mike Ward, global director of content for Informa Pharma Insights, chats with Lamellar Biomedical Ltd's CEO...